Atea Pharmaceuticals Inc. (AVIR)
3.21
0.06 (1.90%)
At close: Jan 15, 2025, 10:15 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | 351.37M | 48.63M | n/a | n/a |
| Cost of Revenue | 70.09M | 260.00K | 29.00K | 19.00K | 17.00K | 17.00K |
| Gross Profit | -70.09M | -260.00K | 351.34M | 48.61M | -17.00K | -17.00K |
| Operating Income | -164.16M | -130.65M | 138.38M | -11.03M | -14.61M | -9.48M |
| Interest Income | 29.22M | 11.15M | 213.00K | 83.00K | 574.00K | 413.00K |
| Pretax Income | -134.94M | -119.50M | 138.59M | -10.95M | -14.03M | -9.06M |
| Net Income | -135.96M | -115.91M | 121.19M | -10.86M | -13.46M | -9.06M |
| Selling & General & Admin | 49.92M | 48.71M | 45.78M | 21.64M | 4.44M | 2.80M |
| Research & Development | 132.84M | 81.94M | 167.21M | 38.02M | 10.17M | 6.67M |
| Other Expenses | -88.69M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 94.07M | 130.65M | 212.99M | 59.66M | 14.61M | 9.48M |
| Interest Expense | n/a | 11.15M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 164.16M | 130.65M | 212.99M | 59.66M | 14.61M | 9.48M |
| Income Tax | 1.02M | -3.59M | 17.40M | -83.00K | -574.00K | 413.00K |
| Shares Outstanding (Basic) | 83.39M | 83.25M | 82.82M | 82.44M | 82.62M | 47.29M |
| Shares Outstanding (Diluted) | 83.39M | 83.25M | 88.25M | 82.44M | 82.62M | 47.29M |
| EPS (Basic) | -1.63 | -1.39 | 1.46 | -0.13 | -0.16 | -0.19 |
| EPS (Diluted) | -1.63 | -1.39 | 1.37 | -0.13 | -0.16 | -0.19 |
| EBITDA | -119.59M | -110.84M | 138.41M | -11.01M | -14.59M | -9.46M |
| Depreciation & Amortization | 416.00K | 260.00K | 29.00K | 19.00K | 17.00K | 17.00K |